Jason Davis insider trades: FibroBiologics (FBLG) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jason reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | FBLG | ↑ Buy | 70,000 | $0.41 | $29K | Direct | Mar 3, 2026 (1d) |
| Jul 17, 2017 | HDYN | ↑ Buy | 34,248 | $1.46 | $50K | Direct | Jul 27, 2017 (10d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other FBLG insiders
Open-market trades in the last 12 months
About Jason Davis's insider trades
Jason Davis is Chief Financial Officer at FibroBiologics (FBLG). Since Jul 17, 2017, Jason has reported 2 open-market purchases worth $79K and no sales on SEC Form 4. In the last 12 months: 1 buy ($29K).
Their filings also include grants and awards (13 filings), option exercises (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FBLG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.